
Biocon unit gets US FDA tentative nod for diabetes drug Sitagliptin
Shares of Biocon ended 0.4% lower at ₹358.60 on Tuesday, valuing the company at about ₹47,943.52 crore.

Shares of Biocon ended 0.4% lower at ₹358.60 on Tuesday, valuing the company at about ₹47,943.52 crore.

Stocks to watch on August 28: Two Tata Group companies, IndiGo, and pharma firms Dr Reddy’s and Biocon have shared significant updates on exchanges. Here’s…

When we look at the company’s performance in the previous quarter, the government-of-India-owned company reported a 42.7% year-on-year (YoY) jump in net profit at ₹798…

Following a seasonally strong Q4 FY2025, revenues of India Inc declined sequentially by around 4.1 per cent in Q1 FY2026, led primarily by sectors like…

In its Q1 results, the company exhibited a strong performance. In the first quarter of FY26, Tata Steel posted a net profit of ₹2,007 crore,…

Nifty broke below the key support level of 24,800, and the fall dragged it under the crucial 50-day EMA. By the close, the index had…

Veritas Finance provides working capital loans to MSMEs in urban and semi-urban areas as well as other as affordable housing loans, used commercial vehicle loans…

From job creation to a potential impact on India’s current account deficit, here are 10 things to know about the potential consequences of a 50%…

As part of this agreement, Zaggle will act as a solutions provider by making its offerings like prepaid payment instruments platform available to corporate customers…

The rally began when Trump noticed the pen during his first in-person meeting with his South Korean counterpart Lee Jae Myung on Monday.